Hisamitsu Pharmaceutical Co Stock

Hisamitsu Pharmaceutical Co ROCE 2024

Hisamitsu Pharmaceutical Co ROCE

0.05

Ticker

4530.T

ISIN

JP3784600003

WKN

864341

In 2024, Hisamitsu Pharmaceutical Co's return on capital employed (ROCE) was 0.05, a 34.79% increase from the 0.04 ROCE in the previous year.

Hisamitsu Pharmaceutical Co Aktienanalyse

What does Hisamitsu Pharmaceutical Co do?

Hisamitsu Pharmaceutical Co Inc is a Japanese company that was founded in 1847. The company is known for its patches and other medical products, making it one of the largest pharmaceutical manufacturers in Japan. The company specializes in the development and production of pharmaceuticals, medical devices, and health and beauty products. They have four main business areas: pharmaceutical products, health products, medical devices, and cosmetics. In addition to their popular Salonpas patches, they also offer a range of other medications, health products, medical devices, and cosmetics. Hisamitsu is committed to improving health and well-being through innovation and collaboration with research institutions and universities. Hisamitsu Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Hisamitsu Pharmaceutical Co's Return on Capital Employed (ROCE)

Hisamitsu Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Hisamitsu Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Hisamitsu Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Hisamitsu Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Hisamitsu Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Hisamitsu Pharmaceutical Co this year?

The ROCE of Hisamitsu Pharmaceutical Co is 0.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Hisamitsu Pharmaceutical Co developed compared to the previous year?

The ROCE of Hisamitsu Pharmaceutical Co has increased by 34.79% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Hisamitsu Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Hisamitsu Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Hisamitsu Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Hisamitsu Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Hisamitsu Pharmaceutical Co impact the company?

An increase in the ROCE of Hisamitsu Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Hisamitsu Pharmaceutical Co affect the company?

A decrease in ROCE of Hisamitsu Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Hisamitsu Pharmaceutical Co?

Some factors that can affect Hisamitsu Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Hisamitsu Pharmaceutical Co so important for investors?

The ROCE of Hisamitsu Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Hisamitsu Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Hisamitsu Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Hisamitsu Pharmaceutical Co pay?

Over the past 12 months, Hisamitsu Pharmaceutical Co paid a dividend of 44.5 JPY . This corresponds to a dividend yield of about 1.11 %. For the coming 12 months, Hisamitsu Pharmaceutical Co is expected to pay a dividend of 45.42 JPY.

What is the dividend yield of Hisamitsu Pharmaceutical Co?

The current dividend yield of Hisamitsu Pharmaceutical Co is 1.11 %.

When does Hisamitsu Pharmaceutical Co pay dividends?

Hisamitsu Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of September, March, September, March.

How secure is the dividend of Hisamitsu Pharmaceutical Co?

Hisamitsu Pharmaceutical Co paid dividends every year for the past 23 years.

What is the dividend of Hisamitsu Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 45.42 JPY are expected. This corresponds to a dividend yield of 1.13 %.

In which sector is Hisamitsu Pharmaceutical Co located?

Hisamitsu Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Hisamitsu Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Hisamitsu Pharmaceutical Co from 11/1/2024 amounting to 2 JPY, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.

When did Hisamitsu Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Hisamitsu Pharmaceutical Co in the year 2023?

In the year 2023, Hisamitsu Pharmaceutical Co distributed 42.75 JPY as dividends.

In which currency does Hisamitsu Pharmaceutical Co pay out the dividend?

The dividends of Hisamitsu Pharmaceutical Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Hisamitsu Pharmaceutical Co

Our stock analysis for Hisamitsu Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Hisamitsu Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.